American Healthcare REIT, Inc.
NYSE:AHRREIT - Healthcare Facilities
-$0.35 today
- Market cap
- $13.59B
- Beta
- 0.81
- P/E (TTM)
- 86.9
- EPS (TTM)
- $0.54
- Dividend yield
- 2.15%
Volume 2.30M
Average 2.50M
AHR Depreciation & Amortization
Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.
American Healthcare REIT, Inc.NYSE: AHR
Depreciation & Amortization · Q3 FY2026 · quarter ended Sep 2026
Depreciation & amortization growth accelerates
Q3 FY2026 depreciation & amortization of $90.87M rose 54.7% year over year, ahead of the +43.2% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 12.0% from the prior quarter. Over 3 fiscal years it compounded at +3.9% a year.
Context
- Depreciation & amortization amounted to 10.0% of revenue in FY2025, down 0.7 pp from a year earlier.
- Depreciation & amortization increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +54.7% holds above the trailing-twelve-month pace of +43.2%.
Sources:Income StatementText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the income statement
- Latest · FY2025
- 225.2M USD
- Year-over-year change
- +1.6%
- 4-year CAGR
- +9.4%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 225.2M | +1.6% |
| FY2024 | 2024-12-31 | 221.64M | -6.6% |
| FY2023 | 2023-12-31 | 237.3M | +18.3% |
| FY2022 | 2022-12-31 | 200.6M | +27.5% |
| FY2021 | 2021-12-31 | 157.38M | — |
Depreciation & Amortization vs competitors
How AHR compares with its peers on the latest reported figures
- AHR's LTM Sep 2026 depreciation & amortization of $312.23M is the 4th highest of the 11 companies compared; the peer median is $164.86M.
- Its year-over-year change of +43.2% is the 2nd highest of 10, against a peer median of +21.7%.
- Depreciation & amortization amounts to 11.7% of revenue for AHR, versus a peer median of 24.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $2.68B | +33.1% | +17.0% | 19.6% | |
| LTM Sep 2026 | $1.1B | +2.4% | +12.9% | 48.9% | |
| LTM Jun 2026 | $330.85M | +4.6% | -0.7% | 25.6% | |
| LTM Sep 2026 | $312.23M | +43.2% | +3.9% | 11.7% | |
MPTMedical Properties Trust, Inc. | LTM Jun 2026 | $281.95M | -26.8% | -7.6% | 27.7% |
| LTM Jun 2026 | $209.43M | +21.7% | -0.1% | 24.4% | |
| LTM Sep 2026 | $120.29M | +58.9% | +22.7% | 19.5% | |
| LTM Sep 2026 | $98.11M | +25.8% | +5.8% | 21.5% | |
NHPNational Healthcare Properties, Inc. (NHP) | LTM Dec 2025 | $80.59M | — | -1.6% | 23.5% |
NHPBPNational Healthcare Properties, Inc. | LTM Mar 2026 | $72.29M | -19.5% | -1.3% | 21.1% |
| LTM Mar 2026 | $46.7M | +25.2% | +17.1% | 29.6% | |
| Peer median (excluding AHR) | $164.86M | +21.7% | +2.8% | 24.0% | |
Competitors are the stored peer set for AHR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.26B | 1.62B | 1.86B | 2.07B | 2.26B |
| Cost of Revenue | 1.08B | 1.28B | 1.5B | 1.65B | 1.79B |
| Gross Profit | 182.01M | 335.97M | 356.83M | 416.78M | 466.59M |
| Gross Margin | 14.4% | 20.8% | 19.2% | 20.1% | 20.6% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 43.2M | 103.1M | 104.99M | 100.8M | 110.17M |
| Operating Expenses | 43.2M | 245.38M | 280.11M | 279.99M | 297.73M |
| Depreciation & Amortization | 157.38M | 200.6M | 237.3M | 221.64M | 225.2M |
| EBITDA | 163M | 233.76M | 324.26M | 315.48M | 359.62M |
| EBITDA Margin | 12.9% | 14.5% | 17.4% | 15.2% | 15.9% |
| Operating Income | 138.81M | 90.59M | 76.72M | 136.79M | 168.87M |
| Operating Margin | 11.0% | 5.6% | 4.1% | 6.6% | 7.5% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 80.94M | 105.96M | 163.19M | 127.73M | 85.78M |
| Other Income / Expenses | (191.12M) | (163.39M) | (152.94M) | (170.67M) | (120.22M) |
| Income Before Tax | (52.31M) | (72.8M) | (76.22M) | (33.89M) | 48.65M |
| Pre-Tax Margin | -4.1% | -4.5% | -4.1% | -1.6% | 2.2% |
| Income Tax Expense | 956K | 586K | 663K | 1.71M | (22.17M) |
| Net Income | (47.79M) | (81.3M) | (71.47M) | (37.81M) | 69.81M |
| Net Margin | -3.8% | -5.0% | -3.8% | -1.8% | 3.1% |
| EPS (Basic) | (0.72) | (1.23) | (1.08) | (0.29) | 0.42 |
| EPS (Diluted) | (0.72) | (1.23) | (1.08) | (0.29) | 0.42 |
| Weighted Avg Shares | 66.21M | 66.21M | 66.05M | 130.64M | 166.06M |
| Weighted Avg Shares (Diluted) | 66.21M | 66.21M | 66.05M | 130.64M | 166.85M |
American Healthcare REIT, Inc.
NYSE:AHR
Intrinsic Alpha fair value
Locked
Current Price
$58.55
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.